| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |